Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 35 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Kitas, George D [Clear All Filters]
(2019).
Can cardiovascular magnetic resonance prompt early cardiovascular/rheumatic treatment in autoimmune rheumatic diseases? Current practice and future perspectives..
Rheumatol Int. 38(6), 949-958.
(2018). Combined brain and heart magnetic resonance imaging in systemic vasculitides: fiction or real need?.
Clin Exp Rheumatol. 36 Suppl 111(2), 152-159.
(2018). Echolucency-based phenotype in carotid atherosclerosis disease for risk stratification of diabetes patients..
Diabetes Res Clin Pract. 143, 322-331.
(2018). The Role of Statins in Disease Modification and Cardiovascular Risk in Rheumatoid Arthritis..
Front Med (Lausanne). 5, 24.
(2018). Biologic drugs as analgesics for the management of osteoarthritis..
Semin Arthritis Rheum. 46(6), 687-691.
(2017). Cardiac Tissue Characterization and Imaging in Autoimmune Rheumatic Diseases..
JACC Cardiovasc Imaging. 10(11), 1387-1396.
(2017). Cardiovascular magnetic resonance imaging pattern at the time of diagnosis of treatment naïve patients with connective tissue diseases..
Int J Cardiol. 236, 151-156.
(2017). Endothelial injury in rheumatoid arthritis: a crosstalk between dimethylarginines and systemic inflammation..
Arthritis Res Ther. 19(1), 32.
(2017). Cumulative inflammation associates with asymmetric dimethylarginine in rheumatoid arthritis: a 6 year follow-up study..
Rheumatology (Oxford). 54(7), 1145-52.
(2015). Imaging Patterns of Cardiovascular Involvement in Mixed Connective Tissue Disease Evaluated by Cardiovascular Magnetic Resonance..
Inflamm Allergy Drug Targets. 14(2), 111-6.
(2015). Molecular and cellular pathways as treatment targets for biologic therapies in systemic sclerosis..
Curr Med Chem. 22(16), 1943-55.
(2015).
(2015).
(2015). Asymmetric dimethylarginine is not associated with subendocardial viability ratio in Rheumatoid Arthritis..
Int J Cardiol. 172(1), 285-6.
(2014). Cardiac and muscular involvement in idiopathic inflammatory myopathies: noninvasive diagnostic assessment and the role of cardiovascular and skeletal magnetic resonance imaging..
Inflamm Allergy Drug Targets. 13(3), 206-16.
(2014). Edema and fibrosis imaging by cardiovascular magnetic resonance: how can the experience of Cardiology be best utilized in rheumatological practice?.
Semin Arthritis Rheum. 44(1), 76-85.
(2014). Individualised exercise improves endothelial function in patients with rheumatoid arthritis..
Ann Rheum Dis. 73(4), 748-51.
(2014). Micro- and macrovascular treatment targets in scleroderma heart disease..
Curr Pharm Des. 20(4), 536-44.
(2014). Neuropathic pain in osteoarthritis: a review of pathophysiological mechanisms and implications for treatment..
Semin Arthritis Rheum. 44(2), 145-54.
(2014). Osteoarthritis pain has a significant neuropathic component: an exploratory in vivo patient model..
Rheumatol Int. 34(3), 315-20.
(2014). Relationship between dimethylarginine dimethylaminohydrolase gene variants and asymmetric dimethylarginine in patients with rheumatoid arthritis..
Atherosclerosis. 237(1), 38-44.
(2014). Rheumatoid arthritis: an autoimmune disease with female preponderance and cardiovascular risk equivalent to diabetes mellitus: role of cardiovascular magnetic resonance..
Inflamm Allergy Drug Targets. 13(2), 81-93.
(2014).
(2014). Biologic therapies and systemic bone loss in rheumatoid arthritis..
Autoimmun Rev. 12(10), 958-66.
(2013).